Up-regulation of rat cortical σ receptors after subchronic administration of rimcazole and 1,3-di(2-tolyl)guanidineMANALLACK, D. T; BEART, P. M.Neuropharmacology. 1988, Vol 27, Num 11, pp 1201-1203, issn 0028-3908Article

Ionic regulation of the binding of DL-2-amino-7-phosphono [4,5-³H] heptanoic acid to synaptosome-enriched homogenates of rat cerebral cortexMANALLACK, D. T; BEART, P. M.Neuroscience letters. 1986, Vol 68, Num 1, pp 11-16, issn 0304-3940Article

Neural networks in drug discovery : have they lived up to their promise?MANALLACK, D. T; LIVINGSTONE, D. J.European journal of medicinal chemistry. 1999, Vol 34, Num 3, pp 195-208, issn 0223-5234Article

Statistics using neural networks : chance effectsLIVINGSTONE, D. J; MANALLACK, D. T.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 9, pp 1295-1297, issn 0022-2623Article

Chiral recognition of structurally related aminoalkylphosphonic acid derivatives on an acetylated beta-cyclodextrin bonded phaseCAMILLERI, P; REID, C. A; MANALLACK, D. T et al.Chromatographia (Wiesbaden). 1994, Vol 38, Num 11-12, pp 771-775, issn 0009-5893Article

Quantitative conformational analyses predict distinct receptor sites for PCP-like and σ drugsMANALLACK, D. T; BEART, P. M.European journal of pharmacology. 1987, Vol 144, Num 2, pp 231-235, issn 0014-2999Article

Subchronic administration of MK-801 in the rat decreases cortical binding of [³H]D-AP5 suggesting down-regulation of the cortical N-methyl-D-aspartate receptorsMANALLACK, D. T; LODGE, D; BEART, P. M et al.Neuroscience. 1989, Vol 30, Num 1, pp 87-94, issn 0306-4522, 8 p.Article

Relating biological activity to chemical structure using neural networksMANALLACK, D. T; LIVINGSTONE, D. J.Pesticide science. 1995, Vol 45, Num 2, pp 167-170, issn 0031-613XArticle

Limitations of functional-link nets as applied to QSAR data analysisMANALLACK, D. T; LIVINGSTONE, D. J.Quantitative structure-activity relationships. 1994, Vol 13, Num 1, pp 18-21, issn 0931-8771Article

A three dimensional receptor model of the dopamine D2 receptor from computer graphic analyses of D2 agonistsMANALLACK, D. T; BEART, P. M.Journal of pharmacy and pharmacology. 1988, Vol 40, Num 6, pp 422-428, issn 0022-3573Article

Regulation of σ-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidineBEART, P. M; O'SHEA, R. D; MANALLACK, D. T et al.Journal of neurochemistry. 1989, Vol 53, Num 3, pp 779-788, issn 0022-3042Article

Platensimycin : A Promising Antimicrobial Targeting Fatty Acid SynthesisMANALLACK, D. T; CROSBY, I. T; KHAKHAM, Y et al.Current medicinal chemistry. 2008, Vol 15, Num 7, pp 705-710, issn 0929-8673, 6 p.Article

Comparison of the properties of [³H]-D-2-amino-5-phosphonopentanoic acid and [³H]-DL-2-amino-7-phosphonoheptanoic acid binding to homogenates of rat cerebral cortexMANALLACK, D. T; SHEEBAN, K.-A. M; BEART, P. M et al.Clinical and experimental pharmacology and physiology. 1989, Vol 16, Num 1, pp 49-58, issn 0305-1870Article

Design, synthesis, and testing of insulin hexamer-stabilizing agentsMANALLACK, D. T; ANDREWS, P. R; WOODS, E. F et al.Journal of medicinal chemistry (Print). 1985, Vol 28, Num 10, pp 1522-1526, issn 0022-2623Article

Absence of N-methyl-D-aspartate receptors on ovine cerebral microvesselsBEART, P. M; SHEEHAN, K.-A. M; MANALLACK, D. T et al.Journal of cerebral blood flow and metabolism. 1988, Vol 8, Num 6, pp 879-882, issn 0271-678XArticle

A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonistsLODGE, D; DAVIES, S. N; JONES, M. G et al.British journal of pharmacology. 1988, Vol 95, Num 3, pp 957-965, issn 0007-1188Article

Analysis of the biological and molecular properties of phencyclidine-like compounds by chemometricsMANALLACK, D. T; DAVIES, J. W; BEART, B. M et al.Arzneimittel-Forschung. 1993, Vol 43, Num 10, pp 1029-1032, issn 0004-4172Article

Evidence for heterogenous glycine domains but conserved multiple states of the excitatory amino acid recognition site of the NMDA receptor : regional binding studies with [³H]glycine and [³H]L-glutamateO'SHEA, R. D; MANALLACK, D. T; CONWAY, E. L et al.Experimental brain research. 1991, Vol 86, Num 3, pp 652-662, issn 0014-4819Article

Receptor site topographies for phencyclidine-like and σ drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analysesMANALLACK, D. T; WONG, M. G; COSTA, M et al.Molecular pharmacology. 1988, Vol 34, Num 6, pp 863-879, issn 0026-895XArticle

Mercaptoacyl matrix metalloproteinase inhibitors : The effect of substitution at the mercaptoacyl moietyBAXTER, A. D; BHOGAL, R; NEIDLE, S et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 21, pp 2765-2770, issn 0960-894XArticle

Multivariate quantitative structure-toxicity relationships in a series of dopamine mimeticsRIDINGS, J. E; MANALLACK, D. T; SAUNDERS, M. R et al.Toxicology (Amsterdam). 1992, Vol 76, Num 3, pp 209-217, issn 0300-483XArticle

Synthesis and Preliminary Screening of Novel Tryptamines as 5-HT₄ Receptor LigandsHANNA-ELIAS, A; MANALLACK, D. T; BERQUE-BESTEL, I et al.Current medicinal chemistry. 2010, Vol 17, Num 25, pp 2775-2787, issn 0929-8673, 13 p.Article

Use of Kv1.3 Blockers for Inflammatory Skin ConditionsNGUYEN, W; HOWARD, B. L; NEALE, D. S et al.Current medicinal chemistry. 2010, Vol 17, Num 26, pp 2882-2896, issn 0929-8673, 15 p.Article